The legislature's own summary of the bill, or its official long title.
Amends various Acts to change references from "epinephrine auto-injector" or "epinephrine injector" to "FDA approved epinephrine delivery device or product". Changes the name of the Epinephrine Injector Act to the FDA Approved Epinephrine Delivery Device or Product Act.
Every action
56 steps, oldest first, as the legislature records them.
Show the 48 earlier steps
HouseFiled with the Clerk by Rep. Joyce Mason
HouseFirst Reading
CommitteeReferred to Rules Committee · House Rules
CommitteeAssigned to Prescription Drug Affordability & Accessibility Committee · House Prescription Drug Affordability
CommitteeDo Pass / Short Debate Prescription Drug Affordability & Accessibility Committee; 013-000-000 · House Prescription Drug Affordability
HousePlaced on Calendar 2nd Reading - Short Debate
HouseAdded Co-Sponsor Rep. Jawaharial Williams
HouseAdded Co-Sponsor Rep. Harry Benton
HouseAdded Co-Sponsor Rep. Dagmara Avelar
HouseSecond Reading - Short Debate
HouseHeld on Calendar Order of Second Reading - Short Debate
HouseAdded Co-Sponsor Rep. Camille Y. Lilly
CommitteeRule 19(a) / Re-referred to Rules Committee · House Rules
HouseAdded Chief Co-Sponsor Rep. Martha Deuter
CommitteeApproved for Consideration Rules Committee; 005-000-000 · House Rules
HousePlaced on Calendar 2nd Reading - Short Debate
HousePlaced on Calendar Order of 3rd Reading - Short Debate
HouseThird Reading - Short Debate - Passed 105-000-000
SenateArrive in Senate
SenatePlaced on Calendar Order of First Reading March 3, 2026
HouseAdded Co-Sponsor Rep. Michelle Mussman
HouseAdded Chief Co-Sponsor Rep. Janet Yang Rohr
SenateChief Senate Sponsor Sen. Suzy Glowiak Hilton
SenateFirst Reading
CommitteeReferred to Assignments · Senate Assignments
CommitteeAssigned to Insurance · Senate Insurance
SenateSenate Committee Amendment No. 1 Filed with Secretary by Sen. Suzy Glowiak Hilton
CommitteeSenate Committee Amendment No. 1 Referred to Assignments · Senate Assignments
CommitteeSenate Floor Amendment No. 2 Motion to Concur Referred to Rules Committee · House Rules
HouseAdded Chief Co-Sponsor Rep. Natalie A. Manley
CommitteeSenate Floor Amendment No. 2 Motion to Concur Rules Referred to Prescription Drug Affordability & Accessibility Committee · House Prescription Drug Affordability
CommitteeSenate Floor Amendment No. 2 Motion to Concur Recommends Be Adopted Prescription Drug Affordability & Accessibility Committee; 013-000-000 · House Prescription Drug Affordability
HouseSenate Floor Amendment No. 2 House Concurs 116-000-000
HouseHouse Concurs
HousePassed Both Houses
HouseSent to the Governor
HouseGovernor Approved
HouseEffective Date January 1, 2027
HousePublic Act . . . . . . . . . 104-0762
Roll calls
6 recorded votes: 3 on the floor, 3 in committee. Each shows how every member voted.